Stay updated on Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.
    Difference
    0.4%
    Check dated 2025-01-12T22:35:19.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-01-05T15:24:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-12-29T09:22:38.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2024-12-22T07:20:53.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.8%
    Check dated 2024-12-14T23:16:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    2%
    Check dated 2024-12-07T18:55:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Post-ASCT in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Post-ASCT in Lymphoma Clinical Trial page.